Pfizer: COVID-19-related Educational Program and Implementation Grants

Pfizer: COVID-19-related Educational Program and Implementation Grants

Award Amount: Up to $250,000
Application Due Date: May 22, 2020

Additional Information:
Recognizing the need for the rapid development of educational programs and trainings and the implementation of systemic best practices for COVID-19 management, Pfizer has released a Request for Proposals (RFP) to provide financial support for organizations producing independent educational programs and quality improvement initiatives designed to combat this evolving crisis.
 
Category A: Independent Medical Education Grants
Through this RFP, it is Pfizer's intent to support educational programs for healthcare providers focused on the recognition, diagnosis, treatment, and overall care management of patients with COVID-19. Specific topics of interest include:

• Overview of the epidemiology, virology, and clinical features of COVID-19
• Summary of the criteria for testing and interpreting the results of laboratory testing
• Recommendations for managing patients with COVID-19 at home and in the hospital
• Counsel for preventing transmission in the clinic and in the community
• Review of Investigational treatments
• Guidance for managing special patient populations during the COVID-19 pandemic
• Retraining on COVID-19 relevant medical procedures (e.g. ventilator management) for clinicians returning to the workforce
• Guidelines on the correct use and procedures of personal protective equipment (PPE)

In addition, Pfizer is interested in supporting programs that include tools designed to help HCP’s educate patients and caregivers on the disease state, preventative measures, and emerging strategies for COVID-19 treatment.
 
Category B: Quality & Process Improvement Grants
The intent of this grant category is to provide support to hospitals or healthcare systems so that they may evaluate and improve their systems-of-care for COVID-19 patients. Funds can be used for staff training or clinical process improvement. While hospitals are dealing with the urgent care of patients with COVID-19, these grants can be used to address procedural challenges and needs. Quality improvement grants can also be used to help facilitate the sharing and exchange of best practices across hospital systems or geographic regions. Pfizer's goal is that the quality or process of care of patients will be improved with this additional funding support.
 
PLEASE NOTE: Given the urgency of care required to meet the demands of the COVID-19 pandemic, it is expected that all educational programs, QI plans, patient education materials, and other tools funded through this grant program will be made publicly available for the entire healthcare community to use.

Link to Complete RFP

If you are interested in applying, please reach out to Lynn Wong or Gwen Allouch with the Office of Advancement.